SYMATESE's strategy is to collaborate with companies willing to develop new biopolymer based medical devices. Companies can subcontract to SYMATESE the design and/or production of finished or semi-finished medical devices. SYMATESE partners will benefit from more than 30 years of experience in biopolymer transformation into medical devices as well as a technical and regulatory support. The collaboration will be handled through a tailor made agreement that will be adapted to the specific situation and needs of the customer.
SYMATESE's offer of services ranges from the development of new specific material, like a new collagen type to the design of new innovative medical devices. SYMATESE's policy is to manufacture the products it has developed for its clients.
Projects are handled and coordinated internally by a project leader who works with a team which includes members of the different services involved.
SYMATESE is accredited as a private research organization by the French ministry of higher education and scientific research.